Univest
Univest
  • Markets

Rupee Near 97 Against the Dollar: Which Indian Stocks Benefit From a Weaker Rupee? IT, Pharma, Chemicals, Textiles and Auto Component Exporters, Who Loses, How to Check Currency Exposure and the Risks

  • October 8, 2026
  • Posted by: Ankit Jaiswal
  • Category: News
No Comments
Rupee Near 97 Against the Dollar: Which Indian Stocks Benefit From a Weaker Rupee? IT, Pharma, Chemicals, Textiles and Auto Component Exporters, Who Loses, How to Check Currency Exposure and the Risks

Rupee near 97/$ (touched 97.15 on 7 Oct). Gainers: IT, pharma, specialty chemicals, textiles, auto parts exporters. Losers: OMCs, airlines, paints, importers. Nifty IT +1.8% on 8 Oct.

Quick Answer

Weaker rupee beneficiaries are companies that earn in dollars and spend in rupees, mainly IT services, pharma, specialty chemicals, textiles and auto component exporters, now that the rupee trades near 97 against the dollar after touching 97.15 on 7 October. One analysis estimates that each Rs 1 of rupee weakness adds about 30 to 50 bps to the operating margin of large IT companies, and pharma firms such as Sun Pharma earn about 66% of gross sales abroad, so both benefit even when volumes are flat. Losers include oil marketing companies, airlines such as IndiGo, paint makers and importers of electronics and chemicals, whose costs rise with the dollar, and the Nifty IT index rose about 1.8% on 8 October while the broader market fell. A weaker rupee alone does not make a stock a buy, since demand, hedging and pricing matter, and the RBI has said the rupee may be undervalued while promising to curb volatility.

Rupee vs dollar moves get attention whenever the currency falls, and the rupee has lost about 9% against the dollar since November 2025. The move has been driven by oil near $101, foreign selling and strong dollar demand, and the RBI sold dollars to smooth the fall.

If you want to know which stocks to look at, this article covers how a weaker rupee affects earnings, the sectors that gain, examples in each, the sectors that lose, a checklist to test currency exposure, the risks and what to watch.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Weaker Rupee: How It Moves Company Earnings
  • IT Stocks and the Rupee Fall
  • Pharma and Healthcare Export Stocks: Another Winner When the Rupee Falls
  • Chemicals, Textiles and Auto Component Export Stocks in the Rupee Fall Trade
  • Who Loses When the Rupee Is Weaker
  • A Checklist to Test Weaker Rupee Exposure
  • Risks in the Weaker Rupee Trade
  • What to Watch Next for the Weaker Rupee
  • Conclusion
  • Frequently Asked Questions
    • Which stocks benefit from a weaker rupee?
    • How much does a weaker rupee help IT margins?
    • Which pharma stocks gain from a weaker rupee?
    • Who loses when the rupee weakens?
    • Where is the rupee vs dollar rate now?
    • Is a weaker rupee always good for exporters?
    • Will the rupee recover?
    • Should I buy export stocks now?

Weaker Rupee: How It Moves Company Earnings

Effect How it works Who is exposed
Higher rupee revenue Each dollar of export revenue converts into more rupees IT, pharma, chemical and textile exporters
Margin gain Costs are mostly in rupees while revenue is in dollars Companies with low import content
Higher input costs Imported crude, components and chemicals cost more rupees Oil marketing companies, airlines, paints, electronics
Debt servicing Dollar loans cost more to repay in rupees Companies with unhedged foreign currency debt
Competitiveness Exports become less expensive for overseas buyers Auto components, textiles, engineering goods

The effect depends on hedging, because many large exporters hedge part of their dollar income, so the gain from the rupee vs dollar move shows up with a lag.

Check the Univest Screener for live data on export stocks

IT Stocks and the Rupee Fall

Point Detail
Margin sensitivity About 30 to 50 bps of operating margin for each Rs 1 of weakness, according to one analysis
8 October move Nifty IT up about 1.8%, led by TCS, HCL Tech, Tech Mahindra and Infosys
Examples TCS, Infosys, HCLTech, Tech Mahindra, Coforge, which earn mainly in dollars and pounds
Caveat Demand is weak: TCS is expected to report about 0.5% sequential growth, so the rupee helps margins but not volumes

The weaker rupee is a tailwind for IT stocks’ margins, but the sector fell about 25% this year on demand and AI worries, so currency alone has not lifted share prices.

Pharma and Healthcare Export Stocks: Another Winner When the Rupee Falls

Company Export link Note
Sun Pharma International markets were 66% of FY26 gross sales; US formulations about Rs 16,800 crore Large dollar revenue base
Divi’s Laboratories Exports active ingredients and intermediates Mega-cap exporter
Strides Pharma North America 51.2% and Europe 21.1% of revenue Highly dollar and pound linked
Piramal Pharma Foreign currency contracts with global clients Rupee sensitive
Dr Reddy’s and Cipla Large US generic businesses Roughly half of revenue from exports for the sector

Pharma also faces US pricing pressure and tariff risks, so a weaker rupee supports earnings without removing those risks.

Download the Univest iOS App or Univest Android App to track IT, pharma and export stocks live.

Chemicals, Textiles and Auto Component Export Stocks in the Rupee Fall Trade

Group Examples Note
Specialty chemicals UPL, Manali Petrochemicals, TGV SRAAC, GNFC, Rain Industries Several small caps rose in the first week of October in one AI-screened portfolio; treat as a screen and not advice
Textiles and yarn Century Enka and other export-oriented makers Competitive against Asian peers
Auto components Exporters of parts to the US and Europe Lower-priced than Chinese and other Asian rivals when the rupee weakens
Healthcare services Narayana Hrudayalaya, Indegene Foreign patients or clients paying in dollars

Small and mid-cap exporters can move sharply on a weaker rupee, so check liquidity and balance sheets before reading too much into a one-week gain.

Who Loses When the Rupee Is Weaker

Group Why Examples
Oil marketing companies Crude is bought in dollars and sold in rupees at controlled prices BPCL, IOC, HPCL
Airlines Fuel and leases are in dollars InterGlobe Aviation
Paints and chemicals importers Imported raw materials and crude derivatives Asian Paints and others
Electronics and consumer durables Imported components Assemblers
Foreign currency borrowers Debt costs more in rupees Companies with unhedged loans
Consumers Imported inflation and costlier foreign travel and study Households

A Checklist to Test Weaker Rupee Exposure

  1. Export share of revenue: the higher, the more a weaker rupee helps.
  2. Import share of costs: a high share offsets the gain.
  3. Hedging policy: heavy hedging delays and lowers the benefit.
  4. Foreign currency debt: a negative if unhedged.
  5. Pricing power and demand: a weaker rupee does not help if orders fall.

Use the checklist before buying any stock on the rupee fall theme, since many companies carry mixed exposures.

Risks in the Weaker Rupee Trade

Rupee reversal: The RBI has said the rupee may be undervalued, and a recovery would cut the gain for exporters.

Weak demand: A weaker rupee helps margins but not volumes in IT and pharma.

Hedging losses: Exporters that hedged earlier may not benefit.

Inflation and rates: A weaker rupee adds to inflation and the case for more RBI hikes.

Crowded trade: Stocks already up on the theme may have priced in the benefit.

What to Watch Next for the Weaker Rupee

  1. The rupee against the 97 mark and any RBI intervention.
  2. TCS results and the commentary from other IT firms.
  3. Q2 results from pharma, chemical and auto component exporters.
  4. Brent crude and US yields.
  5. RBI guidance on the rupee and the next policy in December.

Conclusion

A weaker rupee near 97 helps IT, pharma, specialty chemical, textile and auto component exporters and hurts oil marketing companies, airlines, paints and importers, with Nifty IT up about 1.8% on 8 October. Check export share, hedging and demand before buying, since the RBI may smooth the fall. Consult a SEBI-registered advisor before making any decision.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions

Which stocks benefit from a weaker rupee?

Ans. Exporters earning in dollars, such as IT stocks, pharma, specialty chemicals, textiles and auto components, benefit from a weaker rupee.

How much does a weaker rupee help IT margins?

Ans. One analysis estimates about 30 to 50 bps of operating margin for each Rs 1 of rupee weakness.

Which pharma stocks gain from a weaker rupee?

Ans. Sun Pharma, Divi’s Laboratories, Strides Pharma, Piramal Pharma, Dr Reddy’s and Cipla have large export revenue.

Who loses when the rupee weakens?

Ans. Oil marketing companies, airlines, paint makers, electronics importers and companies with unhedged dollar debt.

Where is the rupee vs dollar rate now?

Ans. Near 97 per dollar, after touching 97.15 on 7 October.

Is a weaker rupee always good for exporters?

Ans. No. Hedging, weak demand and imported costs can offset the gain from a weaker rupee.

Will the rupee recover?

Ans. The RBI has said it may be undervalued and promised to curb volatility, but oil, yields and foreign flows decide the path.

Should I buy export stocks now?

Ans. This article does not constitute investment advice. Consult a SEBI-registered financial advisor.



currency Export Stocks IT Stocks Pharma Stocks Rupee vs Dollar Weaker Rupee
Author: Ankit Jaiswal
Ankit Jaiswal is the Senior Research Analyst at Univest, leading the platform's in-house equity research desk and serving as the editorial reviewer for all research and blog content published at univest.in. With 11+ years of experience in Indian equity markets, he oversees stock recommendations, earnings analysis, sector coverage, and ensures every published article meets SEBI Research Analyst Regulations. He holds a Bachelor of Commerce (B.Com) from St. Xavier's College, Kolkata — one of India's most prestigious commerce institutions — and has cleared CMT Level 2 from the CMT Association, a globally recognised certification in technical analysis and market research. His research methodology combines fundamental analysis (earnings quality, balance sheet strength, management commentary) with advanced technical analysis (chart patterns, momentum indicators, market structure) — giving Univest's retail investors a dual-lens approach that most Indian research platforms lack. Ankit is among the most comprehensively certified analysts in Indian financial media, holding five NISM certifications: Series-XV (Research Analyst), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-VI (Depository Operations), and Series-V-A (Mutual Fund Distributors). At Univest — India's SEBI-registered research and advisory platform — Ankit's responsibilities include leading the research team, finalising stock recommendations published across Pro Lite, Pro Super, and Pro Gold advisory services, and maintaining editorial oversight of all YMYL financial content published on the blog.

Leave a Reply Cancel reply